首页 | 本学科首页   官方微博 | 高级检索  
检索        

帕罗西汀合用阿立哌唑或喹硫平治疗难治性抑郁的对照研究
引用本文:张建.帕罗西汀合用阿立哌唑或喹硫平治疗难治性抑郁的对照研究[J].中国民康医学,2011,23(23):2912+2974.
作者姓名:张建
作者单位:徐州精神病院,江苏徐州,221003
摘    要:目的:探讨阿立哌唑或喹硫平治疗难治性抑郁症的疗效与安全性。方法:48例服用帕罗西汀的难治性抑郁症患者分为阿立哌唑组(24例)和喹硫平组(24例),观察8周。于治疗前和治疗1周、4周及8周末采用汉密尔顿抑郁量表(Hamilton depressive scale,HAMD-17)评定疗效,用不良反应量表(Hamilton depressive scale,TESS)评定不良反应。结果:阿立哌唑组显效率为29.2%,喹硫平组为37.5%。喹硫平组第4周HAMD评分低于阿立哌唑组,差异有显著性。喹硫平组不良反应较少。结论:喹硫平合并帕罗西汀治疗难治性抑郁的疗效好,起效快,且不良反应少。

关 键 词:难治性抑郁  帕罗西汀  喹硫平  阿立哌唑

Efficacy of Paroxetine with Quetiapine or Risperidone in the treatment of refractory depression
ZHANG Jian.Efficacy of Paroxetine with Quetiapine or Risperidone in the treatment of refractory depression[J].medical journal of chinese peoples health,2011,23(23):2912+2974.
Authors:ZHANG Jian
Institution:ZHANG Jian(Xuzhou mental hospital,Jiangsu 221000,China)
Abstract:Objective:To explore the efficacy and safety of Aripiprazole and Quetiapine in the treatment of refractory depression.Methods:48 patients with refractory depression treating of Paroxetine were divided into Aripiprazole group(n=24) and Quetiapine group(n=24) observed for 8 weeks.Hamilton depressive scale(HAMD-17) and Hamilton depressive scale(TESS) were used to evaluate the efficacy and side effects at the end of 1,4,8 week.Results: The response rate of Aripiprazole group and Risperidone group were 29.2% and...
Keywords:Refractory depression  Quetiapine  Aripiprazole  Paroxetine  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号